Published Sep 23, 2026, 3:31 PM ET · Updated 2 months ago · 1 source
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
TechCrunch
·
Original Report
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.